Clomifene
Anovulation
RenJi HospitalSmall moleculePhase 4 / ApprovedDormant
B
62/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 47/ 100
- Competitive Position
- 95/ 100
Competitive context
1 Active assets in the Anovulation cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
CLOMIPHENE CITRATE Xiyuan Hospital of China Academy of Chinese Medical Sciences | Phase 4 | BBB |
Letrozole GABRIEL MONTEIRO PINHEIRO | Phase 4 | BBB |
Metformin Ain Shams Maternity Hospital | Phase 4 | BBB |
Hcg Assiut University | Phase 3 | BB |
Folate University Magna Graecia | Phase 4 | BB |
View all 15 →
Same molecule, other indications
Clomifene is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →